Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Biopharmaceutical Pricing Trend Experts (US)(?)

Council Members in this Study Group: 25

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Adam Fein, PhD, Founder & President, Pembroke Consulting Inc Adam Fein, PhD
Founder & President
Pembroke Consulting Inc

Adam Fein, PhD, is the Founder and President of Pembroke Consulting, Inc., a Philadelphia-based management advisory and business research firm. Dr. Fein is one of the country’s foremost experts on pharmacy economics and the pharmaceutical supply chain. He provides strategic advisory services to a diverse...

Dea Belazi, PharmD, MPH, PAHM, Pharmacy Consultant, Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM
Pharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM

Dea Belazi, PharmD, MPH, PAHM, is currently a consultant working with health plans and pharmaceutical companies. He was previously the Senior Director of Pharmacy Services for Independence Blue Cross, a large commercial and Medicare health plan in Pennsylvania. Prior to this position, he was the Associate...

Tim Gallagher, RPh, Executive Vice President of Pharmacy Operations , Astrup Drug, Inc.Tim Gallagher, RPh
Executive Vice President of Pharmacy Operations
Astrup Drug, Inc.

Tim Gallagher, RPh, is the Executive Vice President of Pharmacy Operations at Astrup Drug, Inc. Minnesota. He manages all aspects of pharmacy operations for the company. Mr. Gallagher has been a practicing pharmacist for 23 years in both the chain and independent community pharmacy setting. He has also...

Vikram Singh, MBA
Director in Health and Productivity Practice
BUCK CONSULTANTS, INC - CC

Vikram Singh, MBA, is a Director in the Health and Productivity Practice at Buck Consultants. His expertise is in the financial and business aspects of pharmacy benefit management. Mr. Singh provides strategic advice in the areas of pharmacy benefit and health care finance, and on mergers and acquisitions...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Pharmacy Groups Oppose First Databank AWP Settlement | 12-03-2008
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

NACDS and FMI filed another brief in opposition to the controversial proposed First Databank settlement, although they overstate their arguments in a few places. I expect this battle to heat up over the next month as we get closer to the late December hearing about First Databank’s settlement. This...

McKesson settlement is next step in the demise of AWP | 12-02-2008
Analysis of: McKesson Agrees To Settlement In Pricing Suits | online.wsj.com
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

McKesson Corp (MCK) settled its pending class action suit for $351 million and set aside a further $143 million reserve for certain future claims. The settlement removes a source of uncertainty for McKesson, but also signals the beginning of the end for the Average Wholesale Price (AWP) benchmark. Average...

CVS Escalates the Generic Price War | 11-13-2008
Analysis of: CVS joins generic drug price war | www.upi.com
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

CVS Caremark (CVS) launched its new Health Savings Pass, which allows customers to buy 90 day supplies of over 400 generics for $9.99 (after paying an enrollment fee of $10). The new program sounds like a logical pre-emptive strike against anticipated share losses. Translation: an old-fashioned, race-to-the-bottom...

New Details on WMT-CAT Pharmacy Deal | 11-06-2008
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

A just-published article in Drug Benefit News provides new details about the Wal-Mart’s (WMT) $0 generic co-pay program with Caterpillar (CAT). Anyone involved in the pharmacy channel – pharmacies, pharmacy benefit managers (PBMs), insurers, payers, drug wholesalers – should be paying attention to the...

Walgreens buys McKesson Specialty Pharmacy: A Win-Win Deal | 11-04-2008
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

Walgreens (WAG) announced the acquisition of McKesson’s (MCK) specialty pharmacy business in a win-win transaction for both companies. The deal makes sense for both parties as long you understand that specialty distributors sell products to physicians, providers and pharmacies, while specialty pharmacies...

View All GLG News by members of this Study Group

GLG InstituteSM Seminars with this Study Group's Leading Experts(?)

 

Recent Seminars

GLGi: Managed Care Formulary
New York, 07-30-2007

Most Common Company Types:

  • Consultancy, Pharma-Focused
  • Healthcare Management
  • Managed Care Health Insurer, For-Profit
  • Pharmaceuticals Manufacturer
  • Pharmacy or Drug Store, Chain
  • Consultancy, Healthcare-Focused
  • Drug Distributor, General or Full-Spectrum
  • Individual/Small Consultancy
  • Lab, Non-Academic/Community Hospital
  • Laboratory, Independent
  • Pharmaceutical Benefits Manager, Large >10 M Lives
  • Pharmaceutical Software, IT & Other
  • Third Party Administrator

Most Common Job Types:

  • President
  • Director
  • Owner
  • Principal
  • Business Development Manager
  • Pharmacist - RPh/PharmD
  • Senior Vice President
  • Medical Director
  • Supply Chain Director
  • Operations Executive
  • Partner
  • Manager
  • Regional Sales Manager
  • Chief Executive Officer
  • Consultant
  • Marketing Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-04T17:45:17.897